Clinical trial
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without…
NCT00079261 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00079261 |
|---|---|
| Title | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma |
| Official title | Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | CHOP regimen, cyclophosphamide, doxorubicin hydrochloride, gemcitabine hydrochloride, prednisone, vincristine sulfate |
| Enrollment | 25 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2007 |
| First posted | Mar 10, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Croatia, Egypt, France, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: